CTEN is Downstream Target of CD24

被引：0
|
作者：
Saira, S. S. [1 ]
Otifi, H. O. Hassan [1 ]
Ghamdi, S. G. Saleh [1 ]
Akhlaq, M. A. Maham [1 ]
Ilyas, M. I. [1 ]
机构：
[1] Univ Nottingham, Nottingham, England
来源：
JOURNAL OF PATHOLOGY | 2016年 / 240卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [1] The CD24 and Kras Signalling Pathways Converge on Cten to Promote Cell Motility in the Colon
    Al-Ghamdi, S.
    Ahmed, M. A.
    Albasri, A.
    Ibrahim, S.
    Jackson, D.
    Kindle, K.
    Ilyas, M.
    JOURNAL OF PATHOLOGY, 2011, 224 : S12 - S13
  • [2] CD24: A Novel Target for Cancer Immunotherapy
    Panagiotou, Emmanouil
    Syrigos, Nikolaos K.
    Charpidou, Andriani
    Kotteas, Elias
    Vathiotis, Ioannis A.
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (08):
  • [3] CD24
    Henniker, AJ
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2001, 15 (02): : 182 - 184
  • [4] CD24 as Biomarker and therapeutic target in GI malignancies
    Shapira, S.
    Kraus, S.
    Kazanov, D.
    Benhar, I.
    Arber, N.
    TUMOR BIOLOGY, 2012, 33 : 45 - 46
  • [5] CD24 is a potential target for treatment of colorectal and pancreatic cancers
    Shapira, Shiran
    Naumov, Inna
    Sagiv, Eyal
    Kazanov, Diana
    Kraus, Sarah
    Arber, Nadir
    CANCER RESEARCH, 2009, 69
  • [6] CD24 is a biomarker for prognosis and therapeutic target in bladder cancer
    Smith, SC
    Nitz, MD
    Frierson, HF
    Theodorescu, D
    LABORATORY INVESTIGATION, 2006, 86 : 162A - 162A
  • [7] CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma
    Freile, Jimena Alvarez
    Avtenyuk, Natasha Ustyanovska
    Corrales, Macarena Gonzalez
    Lourens, Harm Jan
    Huls, Gerwin
    van Meerten, Tom
    Cendrowicz, Ewa
    Bremer, Edwin
    BIOMEDICINES, 2022, 10 (05)
  • [8] CD24 is a biomarker for prognosis and therapeutic target in bladder cancer
    Smith, SC
    Nitz, MD
    Frierson, HF
    Theodorescu, D
    MODERN PATHOLOGY, 2006, 19 : 162A - 162A
  • [9] CD24: Target for a novel anti-metastatic therapeutic
    Overdevest, Jonathan
    Smith, Steven
    Thomas, Shibu
    Theodorescu, Dan
    CANCER RESEARCH, 2009, 69
  • [10] The PI3K-AKT Pathway Is a Downstream Effector of CD24
    Naumov, Inna
    Kraus, Sarah
    Kazanov, Diana
    Shapira, Shiran
    Sagiv, Eyal
    Arber, Nadir
    GASTROENTEROLOGY, 2009, 136 (05) : A308 - A308
12345